comparemela.com
  1. Home
  2. Live Updates
  3. Exosome Cannabinoids Synergism - Breaking News

Latest Breaking News On - Exosome cannabinoids synergism - Page 1 : comparemela.com

Innocan Pharma Corporation: Innocan Pharma Reports Annual 2022 Results with USD 2 6M in Revenue

HERZLIYA, Israel and CALGARY, Alberta, April 18, 2023 /PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") a pharmaceutical technology

Tel avivIris bincovichRoni kamhiInnocan pharmaEva reuterBi sky global ltdPrnewswire innocan pharma corporationInnocan pharma corporationInnocan brandzon coCompany or innocanPharma corporationLiposomes cannabinoidsExosome cannabinoids synergismPremium dermalCentral nervous systemConsumer wellness

Innocan Pharma Reports Annual 2022 Results with USD 2 6M in Revenue

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on.

Tel avivRoni kamhiEva reuterInnocan pharmaIris bincovichInnocan pharma corporationPrnewswire innocan pharma corporationBi sky global ltdCompany or innocanPharma corporationSky globalLiposomes cannabinoidsExosome cannabinoids synergismPremium dermalCentral nervous systemConsumer wellness

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.